Among the 13 predicted hub genes, we observed statistically significant differences in progression-free survival (PFS) and overall survival (OS) for KCNA7 and FOXB1 in NSCLC patients compared to normal lung tissue (P < 0.05) (Figures 5A,B). The gene discussed is KCNA7; the disease is non-small cell lung carcinoma.